Oncotelic Publishes Deciparticle Data Supporting Sapu003 Clinical Trial
Agoura Hills, Calif., July 22, 2026 Oncotelic Therapeutics and Sapu Nano announced the publication of a peer-reviewed study in...
everolimus
Advertisement
Phase III Study Shows Giredestrant Boosts Breast Cancer Survival
Basel, Switzerland — September 22, 2025 — Positive phase III trial results from the evERA study reveal that the...
Advertisement
